Nurse-Led Telemonitoring for Chronic Conditions
What You Need to Know Before You Apply
What is the purpose of this trial?
In Canada, 3 out of 4 Canadians aged 65 and older have at least one chronic condition, while 1 in 4 seniors reported having three or more. Caring for complex patients who usually have multiple chronic conditions (MCC) is one of the biggest challenges facing our healthcare system. For patients, the lack of coordination and continuity of care as they transfer between healthcare settings and healthcare providers (HCPs) often results in a higher risk of readmission, suboptimal and fragmented care plans, delays in required medical intervention, inadequate self-care, and confusion on whom they should contact when they have questions. For the patient's care team, they often have no indication how patients are doing between clinic visits unless the patient can provide a log of their home measurements (e.g., blood pressure). Therefore, they are unable to detect and intervene if their patient's health is worsening between visits.In order to address this increasing need to bridge the current gap in clinical management and self-care of complex patients during their transition from healthcare settings to home care, our team aims to design, implement and evaluate the SMaRT (Safe, Managed, and Responsive Transitions) Clinic, a nurse-led integrated care model facilitated by telemonitoring (TM). Specifically, the SMaRT Clinics aim to meaningfully introduce a nurse (or nurse practitioner) role to improve clinical coordination across patient care teams and reinforce proper self-care education through the use of telemonitoring. This project will be conducted in two phases across four years; Phase I: Design and Development, and Phase II: Implementation and Effectiveness Evaluation. Phase II research activities include enrolling 350 patients with complex chronic conditions in the SMaRT clinics across four study sites. The implementation and effectiveness of the SMaRT clinics will be evaluated through a mix of semi-structured interviews, ethnographic observation, patient questionnaires, and analyses of health utilization outcomes using propensity-matched controls from the ICES provincial database.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, as the trial focuses on telemonitoring for chronic conditions.
Is nurse-led telemonitoring safe for managing chronic conditions?
How does the Nurse-Led Telemonitoring treatment differ from other treatments for chronic conditions?
Nurse-Led Telemonitoring is unique because it allows patients to record their vital signs at home and send this information to nurses who can quickly respond to any health issues, potentially preventing hospital visits. This approach is different from traditional treatments as it emphasizes remote monitoring and timely nurse intervention, which can improve patient outcomes and is particularly beneficial for older adults with long-term conditions.46789
What data supports the effectiveness of the treatment Nurse-Led Telemonitoring for Chronic Conditions?
Research shows that nurse-led telemonitoring can improve outcomes for patients with chronic conditions. For example, a study on diabetes patients found that those using home telemonitoring had a lower death rate compared to those who did not use it. Additionally, patients with asthma reported high satisfaction and reliable results with nurse-led telemonitoring, indicating its feasibility and effectiveness.3481011
Who Is on the Research Team?
Emily Seto, PhD
Principal Investigator
University of Toronto
Are You a Good Fit for This Trial?
The SMaRT Study is for adults over 18 who have recently been discharged from certain hospitals in Canada and have at least one chronic condition like heart failure, COPD, high blood pressure, diabetes, or depression. Participants need to be able to use the telemonitoring app and devices (like a weight scale) and speak English or have someone who can communicate for them.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Design and Development
Design and development of the SMaRT Clinic model and telemonitoring system
Implementation and Effectiveness Evaluation
Implementation of the SMaRT Clinics and evaluation of their effectiveness through various research activities
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Telemonitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Markham Stouffville Hospital
Collaborator
Health Sciences North
Collaborator
William Osler Health System
Collaborator
Women's College Hospital
Collaborator